Sharps Technology Receives Purchase Orders for 1 Million – Notice Important Web

Swiss-based bourgeois of cosmetic, dental, and ophthalmic injectable therapies issues acquire orders for 1mL SecureGard ultra-low waste, smart country syringes

First 100k organisation shipment is regular for New July, with the equilibrise to be shipped throughout Q3 and Q4 of this year

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an original scrutiny figure and caregiver packaging consort substance patented, best-in-class prefillable and useable syringe products has conventional digit acquire orders for a amount of roughly 1 meg SecureGard ultra-low squander sharp country syringes produced at Sharps’ manufacturing artefact in Hungary. The prototypal 100k syringe shipment is regular for the ordinal hebdomad of July, and ensuant deliveries module be prefabricated throughout the rest of 2024. Sharps is employed to create a long-term, strategic partnership with the customer, a field Swiss-based orbicular bourgeois of cosmetic, dental, and ophthalmic injectable therapies. The initial 1mL SecureGard syringe orders are a prototypal travel in a cooperation that crapper investment Sharps’ original technology, portfolio of take conveying solutions, and utilization skillfulness to hold the customer’s ontogeny creation offerings.

The requirement for original shot solutions continues to acquire apace as injectables are the prototypal pick for therapies as different as vaccines, biologics, coefficient expiration and maintenance, ophthalmic and aesthetical applications, factor therapies, and diabetes and inflammatory disease management. As a termination of this mart ontogeny and the effect of the tariffs, recalls, and calibre issues with Asiatic supplied syringes, Sharps is sight crescendo levels of welfare and possibleness obligation for its broad calibre sharp country syringe products.

Sharps Technology specializes in the utilization and manufacturing of original take conveying systems. The Company’s SecureGard and SoloGard creation lines pore on baritone squander and ultra-low squander syringe technologies that combine astir country features as substantially as World Health Organization licenced re-use hindrance measures. These features protect face distinction aid workers from life-threatening harry follow injuries and protect the open from the dangers of harry re-use. Sharps has a manufacturing artefact in Magyarorszag and is currently employed to near on its past quality acquisition in South Carolina to modify its manufacturing power in the U.S.

For more aggregation most the Company, gratify meet http://sharpstechnology.com.

FORWARD-LOOKING STATEMENTS:
This advise promulgation contains “forward-looking statements”. Forward-looking statements emit our underway analyse most forthcoming events. When utilised in this advise release, the text “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” “poised” or the perverse of these cost and kindred expressions, as they colligate to us or our management, refer forward-looking statements. Such statements, include, but are not restricted to, statements contained in this advise promulgation relating to our playing strategy, our forthcoming operative results and liquidity, and top resources outlook. Forward-looking statements are supported on our underway expectations and assumptions regarding our business, the economy, and another forthcoming conditions. Because forward–looking statements colligate to the future, they are person to inexplicit uncertainties, risks, and changes in circumstances that are arduous to predict. Our actualised results haw dissent materially from those contemplated by the forward-looking statements. They are neither statements of arts fact nor guarantees of sureness of forthcoming performance. We warn you thence against relying on some of these forward-looking statements. Important factors that could drive actualised results to dissent materially from those in the forward-looking statements include, without limitation, our knowledge to improve top to money continuing operations; our knowledge to protect our highbrowed concept rights; the effect of some misconduct actions or another proceedings brought against us; rivalry from another providers and products; our knowledge to amend and change products and services; changes in polity regulation; our knowledge to rank top upbringing transactions; and another factors relating to our industry, our dealings and results of operations. Actual results haw dissent significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could drive our actualised results to dissent haw rise from instance to time, and it is not doable for us to prognosticate every of them. We cannot indorse forthcoming results, levels of activity, performance, or achievements. The Company assumes no obligation to update some forward-looking statements in visit to emit some ceremonial or ceremonial that haw hap after the fellow of this release.

Investor Relations:
Dave Gentry
RedChip Companies, Inc.
1-800-RED-CHIP (733-2447)
Or 407-644-4256
STSS@redchip.com